New Value AG

DGAP-Adhoc: NEW VALUE AG: Annual Result 2012/13

NEW VALUE AG  / Key word(s): Final Results

14.06.2013 06:55

Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------

 /

Press Release

New Value's Annual Result  2012/13 (as of March 31, 2013)

Baar, June 14, 2013 - In the financial year 2012/13 the focus was on
restructuring the company and the portfolio companies. With the necessary
measures taken the basis has been laid for the targeted implementation of
the value realization strategy.

All the restructuring measures defined for the period under review were
implemented and the company was stabilized. All shares in the portfolio
company Swiss Medical Solution AG were sold and two minor stakes in other
portfolio companies were disposed of. The bridging loans were repaid in
full and liquidity obtained to ensure the continuation of the company.
Operating costs were reduced significantly (-42% compared to the previous
year). In the current financial year 2013/14 it is planned to further
reduce operating costs by 37% compared to the year under review.

In the financial year 2012/13 New Value had to take further losses
primarily as a result of write-downs and impairments in the portfolio
companies. The Net Asset Value (NAV) of New Value as per March 31, 2013
decreased to CHF 9.73 million (previous year CHF 18.33 million).
Accordingly, the NAV per share decreased to CHF 3.11 from CHF 5.90 at the
beginning of the period. New Value recorded in total a loss of CHF 8.65
million in the financial year 2012/13 (previous year loss of CHF 44.1
million). The loss per share amounted to CHF 2.78.

New Value will publish its annual report 2012/13 with detailed information
on year-end results today. The report will only be published on the website
of New Value (www.newvalue.ch/index.php?id=19&L=1) and only in german. The
General Meeting will take place on August 20, 2013.

About New Value
New Value AG, which is listed on the SIX Swiss Exchange, invests directly
in private companies with strong growth potential in Switzerland and
neighbouring countries. New Value AG provides growth capital to promote
innovative business models and supports the companies to market success.
The companies included in the portfolio are mainly related to the cleantech
and healthcare sectors. New Value is implementing a value realization
strategy and is no longer investing in new companies.

Stock exchange listings:  SIX Swiss Exchange (www.six-swiss-exchange.com)

Ticker symbols  NEWN (CH
Security number   1 081 986
ISIN   CH0010819867
Contact   New Value AG, Zugerstrasse 8a, CH-6340 Baar, Switzerland
   Dr Bernd Pfister
   Phone +41 43 344 38 38
 pfister@newvalue.ch

Information/
downloads www.newvalue.ch Email: info@newvalue.ch


14.06.2013 News transmitted by EQS Group AG.
The issuer is responsible for the contents of the release.

EquityStory publishes regulatory releases, media releases on the capital
market and press releases.
The EquityStory Group distributes authentic and real-time financial news
for over 1'300 listed companies.
The Swiss news archive can be found at www.equitystory.ch/news

---------------------------------------------------------------------------

Language:               English
Company:                NEW VALUE AG
                        Zugerstrasse 8a
                        6340 Baar
                        Switzerland
Phone:                  +41 43 344 38 38
Fax:
E-mail:              info@newvalue.ch
Internet:            www.newvalue.ch
ISIN:                   CH0010819867
Swiss Security Number:  552932
Listed:                 Freiverkehr in Berlin, Düsseldorf, München,
                        Stuttgart; Frankfurt in Open Market ; SIX

End of Announcement                             EquityStory News-Service

---------------------------------------------------------------------------

 



Weitere Meldungen: New Value AG

Das könnte Sie auch interessieren: